UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase III Trial Comparing Paclitaxel Poliglumex (CT-2103, PPX) in Combination with Carboplatin Versus Standard Paclitaxel and Carboplatin in the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer

Journal of thoracic oncology, 2008-06, Vol.3 (6), p.623-630

2008

Volltextzugriff (PDF)

Biological and clinical characterization of paclitaxel poliglumex (PPX, CT-2103), a macromolecular polymer-drug conjugate

International journal of nanomedicine, 2006-01, Vol.1 (4), p.375-383

2006

Volltextzugriff (PDF)

Randomized Phase III Trial Comparing Single-Agent Paclitaxel Poliglumex (CT-2103, PPX) with Single-Agent Gemcitabine or Vinorelbine for the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer

Journal of thoracic oncology, 2008-07, Vol.3 (7), p.728-734

2008

Volltextzugriff (PDF)

Single-Agent Versus Combination Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer and a Performance Status of 2: Prognostic Factors and Treatment Selection Based on Two Large Randomized Clinical Trials

Journal of thoracic oncology, 2009-07, Vol.4 (7), p.869-874

2009

Volltextzugriff (PDF)

phase I and pharmacokinetic study of paclitaxel poliglumex and cisplatin in patients with advanced solid tumors

Cancer chemotherapy and pharmacology, 2009-04, Vol.63 (5), p.903-910

2009

Volltextzugriff (PDF)

Procoagulant inhibitory properties of paclitaxel poliglumex

International journal of general medicine, 2010-12, Vol.4 (default), p.5-11

2010

Volltextzugriff (PDF)

Continuity of research outcomes: The correlation of bench toxicity mechanisms to clinical outcomes—are they dependable?

American journal of kidney diseases, 2002-11, Vol.40 (5), p.1109-1109

Oldham, Fred B.

2002

Volltextzugriff (PDF)

Harvesting and Enrichment of Hematopoietic Progenitor Cells Mobilized Into the Peripheral Blood of Normal Donors by Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) or G-CSF: Potential Role in Allogeneic Marrow Transplantation

Blood, 1995-01, Vol.85 (1), p.275-282

1995

Volltextzugriff (PDF)

Phase I Study of CT-2103, A Polymer-Conjugated Paclitaxel, and Carboplatin in Patients with Advanced Solid Tumors

Cancer investigation, 2005-01, Vol.23 (8), p.671-676

2005

Volltextzugriff (PDF)

P3-019: Serum Cathepsin B (CB) is prognostic and may predict response to therapy in chemotherapy-naive PS2 advanced NSCLC patients treated on two concurrent phase III trials of paclitaxel poliglumex (PPX) vs control treatments (STELLAR 3 and 4)

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S615-S615

2007

Volltextzugriff (PDF)

Selection and Expansion of Peripheral Blood CD34+ Cells in Autologous Stem Cell Transplantation for Breast Cancer

Blood, 1996-03, Vol.87 (5), p.1687-1691

1996

Volltextzugriff (PDF)

Efficacy and safety of paclitaxel poliglumex as first-line chemotherapy in patients at high risk with advanced-stage non-small-cell lung cancer: results of a phase II study

Clinical lung cancer, 2005-11, Vol.7 (3), p.215-220

2005

Volltextzugriff (PDF)

B2-04: Single agent versus combination therapy in advanced NSCLC patients with performance status 2: Results from a regression analysis of STELLAR 3 and 4

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S337-S338

2007

Volltextzugriff (PDF)

Biological and clinical characterization of paclitaxel poliglumex (PPX, CT-2103), a macromolecular polymeradrug conjugate

International journal of nanomedicine, 2006-12, Vol.1 (4), p.375-383

2006

Volltextzugriff (PDF)

92 NOLATREXED PHASE Ib CLINICAL TRIAL IN A DOSE INTENSIFICAITON SCHEDULE IN ADVANCED CANCER PATIENTS

Journal of investigative medicine, 2004-01, Vol.52 (Suppl 1), p.S273-S273

2004

Volltextzugriff (PDF)

Nolatrexed Phase Ib Clinical Trial in a Dose Intensificaiton Schedule in Advanced Cancer Patients

Journal of investigative medicine, 2004-01, Vol.52 (1_suppl_part_4), p.273-273

2004

Volltextzugriff (PDF)

NOLATREXED PHASE Ib CLINICAL TRIAL IN A DOSE INTENSIFICAITON SCHEDULE IN ADVANCED CANCER PATIENTS: 92

Journal of investigative medicine, 2004-01, Vol.52, p.S273

2004

Volltextzugriff (PDF)

Phase I-II study of epirubicin in multiple myeloma

Cancer research (Chicago, Ill.), 1988-11, Vol.48 (21), p.6246-6248

1988

Volltextzugriff (PDF)

Phase I trial of interferon γ retroviral vector administered intratumorally with multiple courses in patients with metastatic melanoma

Human gene therapy, 1999-05, Vol.10 (8), p.1289-1298

1999

Volltextzugriff (PDF)

Dosing regimen of granulocyte-macrophage colony-stimulating factor to support dose-intensive chemotherapy

Journal of clinical oncology, 1992-09, Vol.10 (9), p.1460-1469

1992

Volltextzugriff (PDF)

Phase I-II trial of high-dose epirubicin in patients with lymphoma

Cancer research (Chicago, Ill.), 1987-12, Vol.47 (23), p.6393-6396

1987

Volltextzugriff (PDF)

Perforation of an Unsuspected Cecal Granulocytic Sarcoma during Therapy with Granulocyte-Macrophage Colony-Stimulating Factor

The New England journal of medicine, 1990-02, Vol.322 (5), p.337-338

1990

Volltextzugriff (PDF)

Clinical use of selected and expanded peripheral blood CD34+ cells: a preliminary report of feasibility and safety

Journal of hematotherapy, 1995-12, Vol.4 (6), p.527-529

1995

Volltextzugriff (PDF)

"Raising the Bar" in Extremity Trauma Care: A Story of Collaboration and Innovation

Military medicine, 2016-11, Vol.181 (S4), p.1-2

2016

Volltextzugriff (PDF)

The New Normal of Military Orthopaedic and Rehabilitative Care

Military medicine, 2016-02, Vol.181 (2 Suppl), p.1-1

2016

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Humans
(22)
Female
(13)
Male
(12)
Middle Aged
(12)
Adult
(10)
Aged
(10)
Oncology
(10)
Biological And Medical Sciences
(7)
Medical Sciences
(6)
Aged, 80 And Over
(4)
Antineoplastic Agents
(4)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(4)
General & Internal Medicine
(4)
Hematology
(4)
Lung Neoplasms - Drug Therapy
(4)
Medicine, General & Internal
(4)
Neoplasms - Drug Therapy
(4)
Paclitaxel - Administration & Dosage
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase III Trial Comparing Paclitaxel Poliglumex (CT-2103, PPX) in Combination with Carboplatin Versus Standard Paclitaxel and Carboplatin in the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer

Biological and clinical characterization of paclitaxel poliglumex (PPX, CT-2103), a macromolecular polymer-drug conjugate

Randomized Phase III Trial Comparing Single-Agent Paclitaxel Poliglumex (CT-2103, PPX) with Single-Agent Gemcitabine or Vinorelbine for the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer

Single-Agent Versus Combination Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer and a Performance Status of 2: Prognostic Factors and Treatment Selection Based on Two Large Randomized Clinical Trials

phase I and pharmacokinetic study of paclitaxel poliglumex and cisplatin in patients with advanced solid tumors

Procoagulant inhibitory properties of paclitaxel poliglumex

Continuity of research outcomes: The correlation of bench toxicity mechanisms to clinical outcomes—are they dependable?

Harvesting and Enrichment of Hematopoietic Progenitor Cells Mobilized Into the Peripheral Blood of Normal Donors by Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) or G-CSF: Potential Role in Allogeneic Marrow Transplantation

Phase I Study of CT-2103, A Polymer-Conjugated Paclitaxel, and Carboplatin in Patients with Advanced Solid Tumors

P3-019: Serum Cathepsin B (CB) is prognostic and may predict response to therapy in chemotherapy-naive PS2 advanced NSCLC patients treated on two concurrent phase III trials of paclitaxel poliglumex (PPX) vs control treatments (STELLAR 3 and 4)

Selection and Expansion of Peripheral Blood CD34+ Cells in Autologous Stem Cell Transplantation for Breast Cancer

Efficacy and safety of paclitaxel poliglumex as first-line chemotherapy in patients at high risk with advanced-stage non-small-cell lung cancer: results of a phase II study

B2-04: Single agent versus combination therapy in advanced NSCLC patients with performance status 2: Results from a regression analysis of STELLAR 3 and 4

Biological and clinical characterization of paclitaxel poliglumex (PPX, CT-2103), a macromolecular polymeradrug conjugate

92 NOLATREXED PHASE Ib CLINICAL TRIAL IN A DOSE INTENSIFICAITON SCHEDULE IN ADVANCED CANCER PATIENTS

Nolatrexed Phase Ib Clinical Trial in a Dose Intensificaiton Schedule in Advanced Cancer Patients

NOLATREXED PHASE Ib CLINICAL TRIAL IN A DOSE INTENSIFICAITON SCHEDULE IN ADVANCED CANCER PATIENTS: 92

Phase I-II study of epirubicin in multiple myeloma

Phase I trial of interferon γ retroviral vector administered intratumorally with multiple courses in patients with metastatic melanoma

Dosing regimen of granulocyte-macrophage colony-stimulating factor to support dose-intensive chemotherapy

Phase I-II trial of high-dose epirubicin in patients with lymphoma

Perforation of an Unsuspected Cecal Granulocytic Sarcoma during Therapy with Granulocyte-Macrophage Colony-Stimulating Factor

Clinical use of selected and expanded peripheral blood CD34+ cells: a preliminary report of feasibility and safety

"Raising the Bar" in Extremity Trauma Care: A Story of Collaboration and Innovation

The New Normal of Military Orthopaedic and Rehabilitative Care

Suchergebnisse filtern